Prodrug for tumor therapy
The world market for cancer diagnosis is estimated to be 3.5 billion dollars for 2010. Scientists at the University of Goettingen identified a new diagnostic tumor marker, which shows a general recognition of almost all cancers, an early detection of tumors and a very close causative link to cancer development. Thus, in the nearby future, this marker could also be used as a target for cancer therapy, as seen in first proof of principle experiments. The use in diagnostics of this new tumor marker would be ideal for first line of regular screening and for monitoring of a cancer therapy.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Innovation promises to prevent power pole-top fires
Engineers in Australia have found a new way to make power-pole insulators resistant to fire and electrical sparking, promising to prevent dangerous pole-top fires and reduce blackouts. Pole-top fires pose…
Possible alternative to antibiotics produced by bacteria
Antibacterial substance from staphylococci discovered with new mechanism of action against natural competitors. Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers…
Researchers have found brown fat’s “off-switch
Researchers from the University of Southern Denmark, the Novo Nordisk Center for Adipocyte Signaling (SDU), the University of Bonn and the University Hospital Bonn (UKB) have found a protein that…